Tran Capital Management L.P. Makes New $7.33 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Tran Capital Management L.P. bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 14,809 shares of the healthcare conglomerate’s stock, valued at approximately $7,326,000. UnitedHealth Group accounts for about 0.8% of Tran Capital Management L.P.’s investment portfolio, making the stock its 26th biggest position.

A number of other large investors have also recently made changes to their positions in the stock. Kennedy Capital Management LLC raised its holdings in shares of UnitedHealth Group by 17.7% in the third quarter. Kennedy Capital Management LLC now owns 8,403 shares of the healthcare conglomerate’s stock valued at $4,237,000 after acquiring an additional 1,266 shares in the last quarter. Jackson Wealth Management LLC raised its holdings in UnitedHealth Group by 1.2% in the third quarter. Jackson Wealth Management LLC now owns 14,885 shares of the healthcare conglomerate’s stock worth $7,505,000 after purchasing an additional 182 shares in the last quarter. JT Stratford LLC raised its holdings in UnitedHealth Group by 9.2% in the third quarter. JT Stratford LLC now owns 4,605 shares of the healthcare conglomerate’s stock worth $2,322,000 after purchasing an additional 387 shares in the last quarter. JS Capital Management LLC raised its holdings in UnitedHealth Group by 250.0% in the third quarter. JS Capital Management LLC now owns 35,000 shares of the healthcare conglomerate’s stock worth $17,647,000 after purchasing an additional 25,000 shares in the last quarter. Finally, Shakespeare Wealth Management Inc. acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $205,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

UNH has been the topic of several recent analyst reports. Bank of America restated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 7th. Piper Sandler upped their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, June 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $579.74.

Read Our Latest Stock Report on UNH

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $489.89 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The business’s 50 day moving average price is $498.61 and its 200-day moving average price is $500.96. The firm has a market capitalization of $450.89 billion, a PE ratio of 29.94, a P/E/G ratio of 1.44 and a beta of 0.60. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.26 EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.